 |
|
Implantable device designed to detect, stop seizures under study at MCG
September 11, 2007A small device implanted in the skull that detects oncoming seizures, then delivers a brief electrical stimulus to the brain to stop them is under study at the Medical College of Georgia.
MCG is among 28 U.S. centers participating in a study to determine if the neurostimulator device can help patients whose seizures are not well controlled by drugs.
"The device constantly monitors electrical activity of the brain, gets accustomed to what is normal for that patient and, when it detects activity that is abnormal, within a few milliseconds, sends out a small electrical stimulus to stop it," says Dr. Yong Park, MCG pediatric epileptologist and a principal investigator.
At MCG Medical Center, the RNS™ System, developed by California-based medical device manufacturer NeuroPace, will be used in about 10 patients age 18-70 who have failed to get their seizures controlled with at least two medications. About 240 patients are expected to enroll nationwide.
Eligible participants must have at least three seizures per month and no more than two seizure foci in the brain. Seizure activity is closely monitored through a diary and monthly doctor visits for three months before patients become eligible.
Participants have a device implanted in the skull, with up to two wires containing electrodes placed near the seizure focus. A modified laptop computer looks at electrical activity picked up by the neurostimulator, then is used to program the device to recognize a patient's seizure activity. Physicians can continue to fine-tune the detection and stimulation patterns.
During the first month after implant, the RNS™ is set for detection only while doctors design a set of parameters that allow it to reliably detect the onset of seizure activity, says Dr. Patty Ray, study coordinator. After one month, half of the patients are set for detection and responsive stimulation, the other half continue with detection only. After four months, all devices are set for detection and responsive stimulation throughout the remainder of the two-year study. After the study, patients will be eligible for a study to continue to use the device until it receives FDA approval, Dr. Ray says.
Participants remain on anti-seizure medication throughout the study, although Dr. Park suspects some patients may eventually be weaned off drugs. During this study, researchers also are collecting data on which drugs work best with the neurostimulator.
MCG participated in a smaller feasibility study of the neurostimulator in 2004 and prior to that was among the first centers in the country to use it as an external, temporary measure to try to stop seizures in hospitalized patients whose seizure activity was being monitored, Dr. Park says.
About 1 in 200 people have seizures and about 1 out of 3 cannot get seizures under control with one or more medications. Some people are not candidates for traditional epilepsy surgery to remove the seizure focus because the location increases the risk of problems or deficits, because there are too many foci or because they simply do not want the surgery, Dr. Park says. Early evidence indicates the RNS™ device might be most effective for foci in the medial temporal lobe, an area deep inside the brain involved in memory, where surgery is not an option, he says.
A handful of new drugs, with generally fewer side effects, also have become available in the last few years, giving patients and their doctors more options, he says. MCG has begun studies of three additional anti-seizure medications.
Also on the horizon is a mechanism that delivers a bolus of drug directly to the seizure focus in the brain, which may enhance efficacy and decrease side effects, as well as gene therapy to modify abnormal brain tissue, says Dr. Park, who wants MCG to participate when those studies move to clinical trials.
Medical College of Georgia
At MCG Medical Center, the RNS™ System, developed by California-based medical device manufacturer NeuroPace, will be used in about 10 patients age 18-70 who have failed to get their seizures controlled with at least two medications. About 240 patients are expected to enroll nationwide.
Eligible participants must have at least three seizures per month and no more than two seizure foci in the brain. Seizure activity is closely monitored through a diary and monthly doctor visits for three months before patients become eligible.
Participants have a device implanted in the skull, with up to two wires containing electrodes placed near the seizure focus. A modified laptop computer looks at electrical activity picked up by the neurostimulator, then is used to program the device to recognize a patient's seizure activity. Physicians can continue to fine-tune the detection and stimulation patterns.
During the first month after implant, the RNS™ is set for detection only while doctors design a set of parameters that allow it to reliably detect the onset of seizure activity, says Dr. Patty Ray, study coordinator. After one month, half of the patients are set for detection and responsive stimulation, the other half continue with detection only. After four months, all devices are set for detection and responsive stimulation throughout the remainder of the two-year study. After the study, patients will be eligible for a study to continue to use the device until it receives FDA approval, Dr. Ray says.
Participants remain on anti-seizure medication throughout the study, although Dr. Park suspects some patients may eventually be weaned off drugs. During this study, researchers also are collecting data on which drugs work best with the neurostimulator.
MCG participated in a smaller feasibility study of the neurostimulator in 2004 and prior to that was among the first centers in the country to use it as an external, temporary measure to try to stop seizures in hospitalized patients whose seizure activity was being monitored, Dr. Park says.
About 1 in 200 people have seizures and about 1 out of 3 cannot get seizures under control with one or more medications. Some people are not candidates for traditional epilepsy surgery to remove the seizure focus because the location increases the risk of problems or deficits, because there are too many foci or because they simply do not want the surgery, Dr. Park says. Early evidence indicates the RNS™ device might be most effective for foci in the medial temporal lobe, an area deep inside the brain involved in memory, where surgery is not an option, he says.
A handful of new drugs, with generally fewer side effects, also have become available in the last few years, giving patients and their doctors more options, he says. MCG has begun studies of three additional anti-seizure medications.
Also on the horizon is a mechanism that delivers a bolus of drug directly to the seizure focus in the brain, which may enhance efficacy and decrease side effects, as well as gene therapy to modify abnormal brain tissue, says Dr. Park, who wants MCG to participate when those studies move to clinical trials.
Medical College of Georgia
Seizures Current Events and Seizures News RSSRepeat C-section before 39 weeks raises risk of neonatal illness
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission.
Genetic mutation causes familial susceptibility for degenerative brain disease
Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE).
Study Yields Clues About the Evolution of Epilepsy
Two children have a seizure. One child never has another seizure. Twenty years later, the other child has a series of seizures and is diagnosed with epilepsy. A study being led by researchers at Rensselaer Polytechnic Institute is looking at what could possibly happen in the development of these two children that would lead to such extreme variations in their neurologic health.
Most babies with uncomplicated febrile seizures can avoid spinal tap
When babies develop a fever high enough or abrupt enough to cause a seizure, frightened parents often rush them to the emergency room, where their workup frequently includes a lumbar puncture (spinal tap) to rule out bacterial meningitis.
Peering inside the skull of a mouse to solve meningitis mystery
NYU Langone Medical Center scientists and their collaborators at the Scripps Research Institute in La Jolla, Calif., have discovered an unexpected cause for the fatal seizures seen in mice with viral meningitis, an infection of the central nervous system, according to a study published in the journal Nature.
Yeast mimics severity of mutations leading to fatal childhood illness
Scientists report that human gene mutations expressed in yeast cells can predict the severity of Batten Disease, a fatal nervous system disorder that begins during childhood.
Mayo Clinic finds it generally safe to withdraw anti-seizure medication in children with epilepsy
A new Mayo Clinic study found that it is generally safe to withdraw anti-seizure medications in children with epilepsy who have achieved seizure-freedom while on the medication.
Drops in blood oxygen levels may be key to sudden death in some epilepsy patients
A new study by researchers at UC Davis Medical Center suggests that the sudden unexplained deaths of some epilepsy patients may be a result of their brains not telling their bodies to breathe during seizures.
International team discovers gene associated with epilepsy
A University of Iowa-led international research team has found a new gene associated with the brain disorder epilepsy.
Brain implants may help stroke patients overcome partial paralysis
Scientists have shown for the first time that neuroprosthetic brain implants may be able to help stroke patients with partial paralysis.
More Seizures Current Events and Seizures News Articles
 | Nazi Seizure of Power: The Experience of a Single German Town 1922-1945 (Social Studies: History of the World) by William Allen |
 | Children With Seizures: A Guide For Parents, Teachers, And Other Professionals by Martin L., M.D. Kutscher This concise, accessible handbook for families, friends and carers of children with seizures provides all the information they need to approach seizures from a position of strength. Part 1 discusses types and causes of seizures, and what to do during a seizure. The medical concepts and technical terminology, as well as the available tests and treatments, including anticonvulsant medication, are... |
 | Seizure by Robin Cook The New York Times bestseller is now in paperback. Power, religion, and bioscience collide in the new novel from the master of the medical... |
 | Seizures and Epilepsy in Childhood: A Guide (Johns Hopkins Press Health Book) by John M. Freeman, Eileen P. G. Vining, Diana J. Pillas The award-winning Seizures and Epilepsy in Childhood is the standard resource for parents in need of comprehensive medical information about their child with epilepsy. Now in its third edition, this highly praised book has been thoroughly revised and updated to reflect the latest approaches to the diagnosis and treatment of epilepsy in childhood, including the use of the ketogenic diet as a... |
 | Epilepsy: A Guide to Balancing Your Life (American Academy of Neurology) by Ilo E. Leppik People diagnosed with epilepsy face many difficulties and lifestyle changes, but a proper understanding of the disease is a vital first step toward maintaining a normal life. Written in simple terms, this invaluable resource answers commonly asked questions about epilepsy and explains how it is diagnosed and treated, both with medications and other treatment options. Filled with helpful tables... |
 | Real World Search & Seizure: A Street Handbook for Law Enforcement by Matthew Medina Cut through the complexities of Search & Seizure Law and grab the evidence you need to make your cases stick! Can police lie to get a confession? Must police provide an attorney before a line-up? A suspect asks, Do you think I need an attorney? How do you answer? Can a 3rd party give permission to search someone else s property? Packed with critical answers to a wide range of key Search &... |
 | Taking Seizure Disorders to School: A Story About Epilepsy by Kim Gosselin This story dispels the myths and fears surrounding epilepsy in a positive, upbeat and entertaining style while explaining seizures in an understandable... |
 | Living Well with Epilepsy and Other Seizure Disorders: An Expert Explains What You Really Need to Know by Carl W. Bazil Treatment options, lifestyle strategies,and emotional support for two million Americans. Epilepsy, once mistakenly associated with demonic possession, has for centuries been a poorly understood illness. Today, though it affects nearly one out of every one hundred Americans, little comprehensive information can be found on bookshelves regarding this common and complex neurological disease. Until... |
 | Criminal Investigations and Evidence: Constitutional Principles for Searches, Seizures, Interrogation & ID by Devallis Rutledge |
 | Truman and the Steel Seizure Case: The Limits of Presidential Power (Constitutional Conflicts) by Maeva Marcus Government seizure of the nation’s strikebound steel mills on 8 April 1952 stands as one of President Harry S Truman’s most controversial actions, representing an unprecedented use of presidential power. On 8 June 1952 the United States Supreme Court invalidated Truman’s order with its monumental decision in Youngstown Sheet and Tube Co. v. Sawyer. The history and significance of this case... |
| © 2009 BrightSurf.com |